---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-076592"
form_type: "8-K"
ticker: "TKNO"
cik: "0001850902"
company_name: "Alpha Teknova, Inc."
filed_at: "2026-02-26T23:59:59+00:00"
generated_at: "2026-05-15T23:47:35.518009+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Alpha Teknova reports Q4 and FY2025 revenue growth, provides 2026 guidance of $42-44M

## Summary
- Full year 2025 total revenue $40.5M, up 7% from $37.7M in 2024.
- Q4 2025 revenue $10.0M, up 8% from $9.3M in Q4 2024.
- Clinical Solutions revenue up 47% in Q4 to $2.7M; 25% annual growth in Clinical Solutions customers.
- Net loss improved to $17.3M in 2025 from $26.7M in 2024; Adjusted EBITDA improved to -$6.7M from -$14.5M.
- Company expects 2026 revenue of $42-44M and free cash outflow less than $10M.

## SEC filing metadata
- accession: 0001193125-26-076592
- form_type: 8-K
- ticker: TKNO
- cik: 0001850902
- company_name: Alpha Teknova, Inc.
- filed_at: 2026-02-26T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850902/000119312526076592/0001193125-26-076592-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850902/000119312526076592/tkno-20260226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-076592
- JSON: https://secwatch.observer/filing/0001193125-26-076592.json
- Plain text: https://secwatch.observer/filing/0001193125-26-076592.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.